Research graph
References from Cyclooxygenase-2 Pathway Correlates with VEGF Expression in Head and Neck Cancer. Implications for Tumor Angiogenesis and Metastasis. Local targets link to admitted publications; unresolved targets remain external evidence.
Prostaglandins in squamous cell carcinoma of the larynx: tumor and peritumor synthesis
10.1016/0952-3278(90)90172-h · 1990 · External reference
Increased thromboxane A2 production at primary tumor site in metastasizing squamous cell carcinoma of the larynx
10.1016/0952-3278(93)90042-u · 1993 · External reference
Prognostic significance of prostaglandin E2 production in fresh tissues of head and neck cancer patients
10.1002/hed.2880170206 · 1995 · External reference
Arachidonic acid metabolism: a primer for head and neck surgeons
10.1002/(sici)1097-0347(199807)20:4<334::aid-hed9>3.0.co;2-# · 1998 · External reference
Eicosanoids and the immunology of cancer
10.1007/bf00666103 · 1994 · External reference
Effects of indomethacin on the growth of cultured mammary tumors
10.1002/ijc.2910330316 · 1984 · External reference
Prostaglandins and host defense in cancer
10.1016/s0025-7125(16)31500-0 · 1981 · External reference
Cyclooxygenase-2 expression is upregulated in squamous cell carcinoma of the head and neck
1999 · External reference
Size- and invasion-dependent increase in cyclooxygenase 2 levels in human colorectal carcinomas
1998 · External reference
Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer
10.1093/jnci/90.6.455 · 1998 · External reference
Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas
1998 · External reference
Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester
10.1172/jci116998 · 1994 · External reference
Benzo[a]pyrene up-regulates cyclooxygenase-2 gene expression in oral epithelial cells
10.1093/carcin/18.4.795 · 1997 · External reference
Colorectal cancer and nonsteroidal anti-inflammatory drugs
1997 · External reference
Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2
10.1172/jci119400 · 1997 · External reference
Indomethacin in breast cancer
10.1016/s0140-6736(73)93234-0 · 1973 · External reference
Skin cancers in xeroderma pigmentosum: response to indomethacin and steroids
10.1016/s0140-6736(80)90154-3 · 1980 · External reference
Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet lightinduced skin carcinogenesis
10.1002/(sici)1098-2744(199908)25:4<231::aid-mc1>3.0.co;2-f · 1999 · External reference
Inhibition of head and neck tumor cell growth with arachidonic acid metabolism inhibition
10.1097/00005537-199602000-00003 · 1996 · External reference
Role of arachidonic acid metabolites in tumor growth inhibition by nonsteroidal antiinflammatory drugs
10.1016/s0196-0709(97)90041-7 · 1997 · External reference
Regression of head and neck carcinoma with a prostaglandin-synthesis inhibitor
10.1001/archotol.1981.00790470006003 · 1981 · External reference
Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice
1998 · External reference
Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostagladin endoperoxide synthase 2
10.1016/0092-8674(95)90127-2 · 1995 · External reference
Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential
10.1073/pnas.94.7.3336 · 1997 · External reference
Cyclooxygenase regulates angiogenesis induced by colon cancer cells
10.1016/s0092-8674(00)81433-6 · 1998 · External reference
Vascular endothelial cell growth factor (VEGF) produced by A-431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites
10.1073/pnas.88.13.5819 · 1991 · External reference
Cyclooxygenase-2 expression in human esophageal carcinoma
1999 · External reference
Tumor angiogenesis and metastasis. Correlation in invasive breast carcinoma
10.1056/nejm199101033240101 · 1991 · External reference
Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cells
10.1038/sj.onc.1201201 · 1997 · External reference
Expression pattern of vascular endothelial growth factor isoform is closely correlated with tumor stage and vascularization in renal cell carcinoma
10.1016/s0959-8049(98)00278-0 · 1999 · External reference
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
10.1021/bi00591a005 · 1979 · External reference
Steroid hormone receptor immunchistochemistry and amplification of c-myc protooncogene. Relationship to disease-free survival in breast cancer
10.1002/1097-0142(19930101)71:1<162::aid-cncr2820710126>3.0.co;2-1 · 1993 · External reference
Effects of OKY 046, a thromboxane-synthase inhibitor, on renal function in nonazotemic cirrhotic patients with ascites
10.1016/0016-5085(88)90688-9 · 1988 · External reference
Angiogenesis and tumor progression are under the control of nitric oxide in head and neck cancer
10.1093/jnci/90.8.587 · 1998 · External reference
Nonsteroidal antiinflammatory drugs cause apoptosis and induce cyclooxygenases in chicken embryo fibroblasts
10.1073/pnas.92.17.7961 · 1995 · External reference
Angiogenesis
10.1016/s0021-9258(19)49853-0 · 1992 · External reference
Vascular endothelial growth factor is a secreted angiogenic mitogen
10.1126/science.2479986 · 1991 · External reference
Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma
10.1002/(sici)1097-0142(19970115)79:2<206::aid-cncr2>3.0.co;2-i · 1997 · External reference
Vascular endothelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significance
1997 · External reference
Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors
2000 · External reference
Induction of vascular endothelial growth factor expression of prostaglandin E2 and El in osteoblasts
10.1172/jci117258 · 1994 · External reference
PGE2 and angiogenesis
10.3181/00379727-172-41548 · 1983 · External reference
Inhibition of angiogenesis by nonsteroidal antiinflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing
10.1038/70995 · 1999 · External reference
Host cyclooxygenase-2 modulates carcinoma growth
10.1172/jci9621 · 2000 · External reference
Expression of cyclooxygenase1 and -2 in human colorectal cancer
1995 · External reference
Vascular endothelial growth factor promotes tumor dissemination by a mechanism distinct from its effect on primary tumor growth
1996 · External reference
Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation
10.1172/jci117185 · 1994 · External reference
Regulation of prostaglandin production by nitric oxide; an in vivo analysis
10.1111/j.1476-5381.1995.tb13330.x · 1995 · External reference
Novel triterpenoids suppress inducible nitric oxide synthase (iNOS) and inducible cyclooxygenase (COX-2) in mouse macrophages
1998 · External reference
Regulation of the inducible cycle -oxygenase pathway in human cultered airway epithelial (A549) cells by nitric oxide
10.1038/sj.bjp.0701283 · 1997 · External reference
p53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells
10.1038/3957 · 1998 · External reference
Up-regulation of inducible nitric oxide synthase expression in cancer-prone p53 knockout mice
10.1073/pnas.95.15.8823 · 1998 · External reference
Loss of the p53 mutation after irradiation is associated with increased aggressiveness in recurred head and neck cancer
1996 · External reference
iNOS and p53 as playmakers of tumor angiogenesis
1998 · External reference
